| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.5 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |